Sublingual spray formulation comprising dihydroartemesinin

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/335 (2006.01) A61K 9/12 (2006.01)

Patent

CA 2756925

The invention provides pharmaceutical compositions for the treatment of neoplastic diseases, fluke infestations and Lyme disease, comprising compounds capable of providing dihydroartemesinin and a medium chain triglyceride formulated for transmucosal sublingual, buccal or nasal delivery, especially by a spray. Also provided are delivery devices containing the compo-sitions.

L'invention porte sur des compositions pharmaceutiques pour le traitement de maladies néoplasiques, d'infestations par la douve et de la maladie de Lyme, comprenant des composés capable de fournir de la dihydroartémésinine et un triglycéride à chaîne moyenne formulées pour une administration transmucosale, sublinguale, buccale ou nasale, notamment par pulvérisation. L'invention porte également sur des dispositifs d'administration contenant les compositions.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Sublingual spray formulation comprising dihydroartemesinin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Sublingual spray formulation comprising dihydroartemesinin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Sublingual spray formulation comprising dihydroartemesinin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1491642

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.